dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
Published 6 years ago • 235 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:46
dr. rimawi on treatment of metastatic her2 breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
1:56
dr. rimawi discusses katherine trial in her2 breast cancer
-
1:13
dr. rimawi discusses patient selection in her2 breast cancer
-
1:32
dr. rimawi on neoadjuvant estrogen deprivation therapy in her2 breast cancer
-
1:50
dr. rimawi discusses role of tkis in her2 breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
6:06
immunotherapy in breast cancer
-
1:32
dr. verma on immunotherapy in her2 breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
1:00
dr. carey on possibility of immunotherapy in her2 breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
1:06
immunotherapy combination in her2-positive breast cancer
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer